info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Biosafety Cabinets Market Research Report Information By Type (Class I, Class II and Class III), By End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Testing Laboratories, Academic Research Institutes) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/20455-HCR | 128 Pages | Author: Rahul Gotadki| September 2024

Biosafety Cabinets Market Segmentation


Biosafety Cabinets Type Outlook (USD Billion, 2019-2032)




  • Class I




  • Class II




  • Class III




Biosafety Cabinets End User Outlook (USD Billion, 2019-2032)




  • Pharmaceutical and Biopharmaceutical Companies




  • Diagnostic and Testing Laboratories




  • Academic Research Institutes




Biosafety Cabinets Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)




    • North America Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • North America Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • US Outlook (USD Billion, 2019-2032)




    • US Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • US Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • CANADA Outlook (USD Billion, 2019-2032)




    • CANADA Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • CANADA Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes








  • Europe Outlook (USD Billion, 2019-2032)




    • Europe Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Europe Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Germany Outlook (USD Billion, 2019-2032)




    • Germany Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Germany Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • France Outlook (USD Billion, 2019-2032)




    • France Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • France Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • UK Outlook (USD Billion, 2019-2032)




    • UK Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • UK Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • ITALY Outlook (USD Billion, 2019-2032)




    • ITALY Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • ITALY Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • SPAIN Outlook (USD Billion, 2019-2032)




    • Spain Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Spain Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Rest Of Europe Outlook (USD Billion, 2019-2032)




    • Rest Of Europe Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • REST OF EUROPE Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes








  • Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Asia-Pacific Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Asia-Pacific Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • China Outlook (USD Billion, 2019-2032)




    • China Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • China Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Japan Outlook (USD Billion, 2019-2032)




    • Japan Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Japan Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • India Outlook (USD Billion, 2019-2032)




    • India Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • India Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Australia Outlook (USD Billion, 2019-2032)




    • Australia Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Australia Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Rest of Asia-Pacific Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Rest of Asia-Pacific Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes








  • Rest of the World Outlook (USD Billion, 2019-2032)




    • Rest of the World Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Rest of the World Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Middle East Outlook (USD Billion, 2019-2032)




    • Middle East Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Middle East Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Africa Outlook (USD Billion, 2019-2032)




    • Africa Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Africa Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes






    • Latin America Outlook (USD Billion, 2019-2032)




    • Latin America Biosafety Cabinets by Type




      • Class I




      • Class II




      • Class III






    • Latin America Biosafety Cabinets by End User




      • Pharmaceutical and Biopharmaceutical Companies




      • Diagnostic and Testing Laboratories




      • Academic Research Institutes







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL BIOSAFETY CABINETS MARKET, BY TYPE

6.1. Overview

6.2. Class I

6.3. Class II

6.4. Class III

7. GLOBAL BIOSAFETY CABINETS MARKET, BY END USER

7.1. Overview

7.2. Pharmaceutical and Biopharmaceutical Companies

7.3. Diagnostic and Testing Laboratories

7.4. Academic Research Institutes

8. GLOBAL BIOSAFETY CABINETS MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Biosafety Cabinets Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Biosafety Cabinets Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2023

9.8.2. Major Players R&D Expenditure. 2023

10. COMPANY PROFILES

10.1. Thermo Fisher Scientific

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Kewaunee Scientific

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Labconco

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Esco Micro

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. The Baker Company

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. NuAire

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Germfree Laboratories

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. CRUMA

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Air Science

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Berner International

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL BIOSAFETY CABINETS MARKET, SYNOPSIS, 2024-2032

TABLE 2 GLOBAL BIOSAFETY CABINETS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 7 US: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 8 US: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 9 CANADA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 10 CANADA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 3 GERMANY: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 5 FRANCE: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 6 FRANCE: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 7 ITALY: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 8 ITALY: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 9 SPAIN: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 10 SPAIN: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 11 UK: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 12 UK: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 17 JAPAN: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 18 JAPAN: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 19 CHINA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 20 CHINA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 21 INDIA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 22 INDIA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 23 AUSTRALIA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 24 AUSTRALIA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 33 AFRICA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 34 AFRICA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY TYPE, 2019-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIOSAFETY CABINETS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIOSAFETY CABINETS MARKET

FIGURE 4 GLOBAL BIOSAFETY CABINETS MARKET, SHARE (%), BY TYPE, 2023

FIGURE 5 GLOBAL BIOSAFETY CABINETS MARKET, SHARE (%), BY END USER, 2023

FIGURE 6 GLOBAL BIOSAFETY CABINETS MARKET, SHARE (%), BY REGION, 2023

FIGURE 7 NORTH AMERICA: BIOSAFETY CABINETS MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 EUROPE: BIOSAFETY CABINETS MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 ASIA-PACIFIC: BIOSAFETY CABINETS MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 REST OF THE WORLD: BIOSAFETY CABINETS MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 GLOBAL BIOSAFETY CABINETS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 12 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS

FIGURE 14 KEWAUNEE SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 KEWAUNEE SCIENTIFIC: SWOT ANALYSIS

FIGURE 16 LABCONCO: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 LABCONCO: SWOT ANALYSIS

FIGURE 18 ESCO MICRO: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 ESCO MICRO: SWOT ANALYSIS

FIGURE 20 THE BAKER COMPANY.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 THE BAKER COMPANY.: SWOT ANALYSIS

FIGURE 22 NUAIRE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 NUAIRE: SWOT ANALYSIS

FIGURE 24 GERMFREE LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 GERMFREE LABORATORIES: SWOT ANALYSIS

FIGURE 26 CRUMA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 CRUMA: SWOT ANALYSIS

FIGURE 28 AIR SCIENCE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 AIR SCIENCE: SWOT ANALYSIS

FIGURE 30 BERNER INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 BERNER INTERNATIONAL: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.